Welcome to LookChem.com Sign In|Join Free

CAS

  • or

125313-99-7

Post Buying Request

125313-99-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125313-99-7 Usage

Description

3-(4-Chlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione is a complex chemical compound characterized by a pyrrole ring with a 4-(1-methyl-1H-indol-3-yl) substituent and a 3-(4-chlorophenyl) substituent. This pyrrole-2,5-dione is recognized for its potential applications in pharmaceutical and research fields, where it is utilized for the synthesis of new drugs and as a research tool to study various biological processes. Its unique molecular structure may also confer specific pharmacological or biological activities, attracting the attention of researchers and pharmaceutical companies.

Uses

Used in Pharmaceutical Industry:
3-(4-Chlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione is used as a key intermediate in the synthesis of new drugs for various therapeutic areas. Its unique molecular structure allows for the development of compounds with novel pharmacological properties, contributing to the advancement of medicinal chemistry.
Used in Research Applications:
In the research field, 3-(4-Chlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione serves as a valuable research tool for studying biological processes. Its specific molecular structure enables researchers to investigate its interactions with biological targets, providing insights into the underlying mechanisms of action and potential applications in drug discovery.
Used in Drug Discovery:
3-(4-Chlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione is employed in drug discovery efforts to identify new lead compounds with potential therapeutic applications. Its unique chemical properties and interactions with biological targets make it a promising candidate for the development of innovative drugs to address unmet medical needs.
Used in Chemical Synthesis:
3-(4-Chlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione is utilized in chemical synthesis processes to create a variety of compounds with diverse applications. Its versatile molecular structure allows for the formation of new chemical entities, expanding the scope of synthetic chemistry and enabling the development of novel materials and compounds with specific properties.

Check Digit Verification of cas no

The CAS Registry Mumber 125313-99-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,3,1 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 125313-99:
(8*1)+(7*2)+(6*5)+(5*3)+(4*1)+(3*3)+(2*9)+(1*9)=107
107 % 10 = 7
So 125313-99-7 is a valid CAS Registry Number.

125313-99-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-chlorophenyl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione

1.2 Other means of identification

Product number -
Other names 3-(4-CHLOROPHENYL)-4-(1-METHYL-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125313-99-7 SDS

125313-99-7Downstream Products

125313-99-7Relevant articles and documents

Synthesis and initial in vivo studies with [11C]SB-216763: The first radiolabeled brain penetrative inhibitor of GSK-3

Li, Lei,Shao, Xia,Cole, Erin L.,Ohnmacht, Stephan A.,Ferrari, Valentina,Hong, Young T.,Williamson, David J.,Fryer, Tim D.,Quesada, Carole A.,Sherman, Phillip,Riss, Patrick J.,Scott, Peter J. H.,Aigbirhio, Franklin I.

supporting information, p. 548 - 552 (2015/05/27)

Quantifying glycogen synthase kinase-3 (GSK-3) activity in vivo using positron emission tomography (PET) imaging is of interest because dysregulation of GSK-3 is implicated in numerous diseases and neurological disorders for which GSK-3 inhibitors are bei

Substituted pyrroles

-

, (2008/06/13)

Compounds of the formula STR1 wherein R1, R2, R3, R4, R5, R6, R7, X and Y have the signficance given in the description, are useful in the control or prevention of inflammatory, immunological, bronchopulmonary or cardiovascular disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 125313-99-7